Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iplex in Children with GHIS (Laron Syndrome)
NCT00368173Phase 3Completed
- Sponsor
- Insmed Incorporated
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 14
01
Overview
A Phase 3 trial of mecasermin rinfabate in Laron syndrome (LS), sponsored by Insmed Incorporated. Status: completed.
02
Drugs
mecasermin rinfabate
03
Conditions
Laron syndrome (LS)
Beyond the preview
Go deeper on NCT00368173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368173.